DMF Medical
DMF Medical is a Canadian medical device company founded in 2011 that sells mem*sorb™, a patented membrane-based CO2 filter for anesthetic circuits, directly to hospitals using Dräger and GE anesthesia machines. The device replaces daily chemical absorbers with a 24-month reusable filtration unit.
- Company typePrivate
- Founded2011
- HeadquartersHalifax, Canada
- Headcount11–50
- GTM typeB2B
- OfferingHardware or Manufacturing
What DMF Medical does
DMF Medical Incorporated is a Canadian medical device company founded in 2011 and headquartered in Dartmouth, Nova Scotia. The company develops and commercializes mem*sorb™, a next-generation CO2 filter for anesthetic circuits that uses patented polymeric hollow fiber membrane technology to passively separate CO2 from the re-breathing circuit, replacing the traditional chemical CO2 absorbents used in anesthesia machines. mem*sorb™ is offered in two machine-specific variants — MS-DR for Dräger Fabius, Primus, Perseus, and Zeus workstations, and MS-GE for GE Aisys machines — with a 24-month useful life that eliminates the daily replacement cycle of single-use chemical absorbers and reduces machine-side moisture, dust, and chemical by-product exposure.
The company's business model is a direct enterprise hardware sale to hospitals and medical centers, with units priced at cost-per-hour-of-surgery parity to chemical absorbers and replacement cycles of up to 24 months. The product is currently licensed for sale in Canada only, with CE-marked IFU-EU versions referenced, indicating preparatory activity for European markets. The go-to-market motion is enterprise field sales supported by a professional product support team and content marketing through the memsorb.com website, with clinical evidence presented at anesthesiology conferences such as ESA and NAVAt.
DMF Medical operates as a privately held corporation with no disclosed institutional investors, funding rounds, leadership team bios, headcount, or revenue figures. The technology has a single-product, single-product-line architecture anchored on patented membrane science, and the value proposition is supported by clinical data indicating 35%+ reductions in anesthetic vapor consumption when paired with low-flow anesthesia techniques, alongside the elimination of recurring chemical waste, storage, and disposal logistics.
DMF Medical firmographics
Firmographics- Name
- DMF Medical
- Legal name
- DMF Medical Incorporated
- Website
- https://dmfmedical.com
- Company type
- Private
- Founded year
- 2011
- Operating status
- Operating
- Headcount range
- 11–50 employees
- Short description
- DMF Medical is a Canadian medical device company founded in 2011 that sells mem*sorb™, a patented membrane-based CO2 filter for anesthetic circuits, directly to hospitals using Dräger and GE anesthesia machines. The device replaces daily chemical absorbers with a 24-month reusable filtration unit.
- Ownership category
- akta.pro rank
DMF Medical industry classification
Industry- Product category
- Anesthesia CO2 Filtration Medical Devices
- NAICS
- Surgical Appliance and Supplies Manufacturing (339113)
- akta.pro primary industry
- Anesthesia & Respiratory Gas Delivery Equipment (Breathing Circuits, Vaporizers, Gas Mixers) (HLAHAGAK)
Keywords
Where DMF Medical is headquartered
LocationHeadquarters
- HQ city
- Halifax
- HQ country
- Canada
- HQ region
- North America
Offices1 record
Markets served
DMF Medical business model
Business model- GTM type
- B2B
- Offering type
- Hardware or Manufacturing
- Cost components
- Supply Chain, Technology or R&D, Personnel, Marketing or Sales, Operations
Revenue model
- Medical Device Sales (mem*sorb™): Sale of mem*sorb™ CO2 filter devices to hospitals and medical centers. Priced at equivalent cost per hour of surgery compared to traditional single-use chemical absorbers, while eliminating inventory, storage, and disposal costs. Revenue is generated through product sales with 24-month replacement cycle per unit.
Pricing tiers
| Model | Billing | Price |
|---|---|---|
| Unit Pricing | Multi-year contract | Unit pricing based on cost-per-hour of surgery equivalent to chemical absorbers |
Go-to-market motion1 record
Distribution channels1 record
Marketing channels3 records
DMF Medical product offering
Product offeringCore offering
DMF Medical designs, manufactures, and sells mem*sorb™, a next-generation CO2 filter for anesthetic circuits that uses patented polymeric hollow fiber membrane technology to separate CO2 from the re-breathing circuit via passive diffusion. The product replaces traditional single-use chemical CO2 absorbents used on Dräger and GE Aisys anesthesia machines, offering a 24-month useful life and is sold directly to hospitals and medical centers.
Product overview
DMF Medical offers a single unified product — mem*sorb*™ — a next-generation CO2 filter for anesthetic circuits. The product uses patented membrane technology to filter CO2 from anesthetic circuits rather than absorption via chemical reaction. Two variants are available: MS-DR (compatible with Dräger Fabius, Primus, Perseus, and Zeus anesthesia machines) and MS-GE (compatible with GE Aisys anesthesia machines). Both variants offer up to 24 months of useful life, significantly longer than traditional single-use chemical absorbers.
Differentiator
Problem solved
Functional benefit
Brands
- mem*sorb™: Next-generation CO2 filter for anesthetic circuits using patented membrane technology. The product is compatible with Dräger and GE anesthesia machines and has a 24-month useful life.
Products and services
- mem*sorb™ (MS-DR) — Dräger-compatible CO2 filter for anesthetic circuits Next-generation CO2 filter for anesthetic circuits using patented polymeric hollow fiber membrane technology; replaces daily chemical CO2 absorbents on Dräger Fabius, Primus, Perseus, and Zeus anesthesia machines and offers a 24-month useful life. Targeted at hospitals and medical centers performing surgery under general anesthesia.
- mem*sorb™ (MS-GE) — GE Aisys-compatible CO2 filter for anesthetic circuits Machine-specific variant of mem*sorb™ that clicks into place on GE Aisys anesthesia machines in place of the existing chemical CO2 absorber; uses the same patented membrane technology with a 24-month useful life. Targeted at hospitals and medical centers using GE Aisys anesthesia platforms.
Quantifiable outcome
- Anesthetic vapor consumption reduced by 35%+ when anesthesiologists adopt low-flow techniques enabled by membrane filtration
- +2 more outcomes
Companies that use DMF Medical
Customer profileSegments1 record
Ideal customer profiles1 record
DMF Medical technology and API
TechnologyTechnology focussed No
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
Integration2 records
Feature4 records
DMF Medical partnerships and signals
Strategic signalScale indicators3 records
Recent moves5 records
Expansion highlights4 records
DMF Medical competitors and assessment
Company assessmentDirect peers
- Teleflex: Teleflex offers anesthesia and respiratory products including CO2 absorbents and breathing circuit components, placing it in direct competition with mem*sorb™ across hospital anesthesia consumables.
- Penlon: Penlon manufactures anesthesia equipment and related consumables, including CO2 absorbents used in its anesthesia workstations, competing with mem*sorb™ in the CO2 absorption segment of the anesthesia circuit.
- Intersurgical: Intersurgical manufactures respiratory care and anesthesia products, including Spherasorb and other chemical CO2 absorbents that compete directly with mem*sorb™ in the anesthesia breathing circuit. Direct overlap in CO2 absorption and breathing circuits makes it the most comparable peer.
- Armstrong Medical: Armstrong Medical supplies anesthesia consumables including CO2 absorbents, positioning it as a direct competitor to mem*sorb™ for hospital anesthesia circuit replacement products.
- Vyaire Medical: Vyaire Medical is a respiratory care specialist with a product portfolio overlapping anesthesia breathing circuits and gas management, comparable to mem*sorb™'s hospital respiratory focus.
Broad incumbents
- ICU Medical (Smiths Medical): ICU Medical's Smiths Medical business supplies anesthesia and respiratory devices, including airway and gas management products, providing overlapping offerings to the same hospital customers as DMF Medical.
- GE HealthCare: GE HealthCare manufactures the Aisys anesthesia machines that mem*sorb™ is designed to integrate with. As a large incumbent with broad perioperative offerings, GE is both an enabling OEM and a competitor for the CO2 absorption consumable category.
- Dräger: Dräger is a leading anesthesia machine manufacturer (Fabius, Primus, Perseus, Zeus) whose hardware mem*sorb™ is designed to integrate with. Dräger also offers consumables and absorbers within its broader perioperative portfolio, making it both an OEM partner and a competitive threat.
- Philips: Philips operates broadly in hospital respiratory and perioperative care including patient monitoring and ventilation, adjacent to DMF Medical's anesthesia gas management focus as a large incumbent in the same hospital customer base.
Others
- Medline Industries: Medline is a major medical supplies distributor and manufacturer whose anesthesia and respiratory offerings touch the same hospital procurement channels DMF Medical targets, even though its portfolio is broader and not focused on CO2 filtration specifically.
Market position
Strengths5 records
Weaknesses5 records
Competitive moat4 records
Key risks5 records
Key highlights6 records
Customer concentration
DMF Medical social profiles
Digital presenceDMF Medical compliance and trust
Trust signalCompliance1 record
DMF Medical financial estimates
Financial estimateRevenue estimate
Valuation estimate
DMF Medical leadership team
Management profileNumber of profiles
DMF Medical funding detail
Funding detailFunding overview
Funding rounds2 records
Investors2 records
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
DMF Medical M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about DMF Medical
What does DMF Medical do?
DMF Medical designs, manufactures, and sells mem*sorb™, a next-generation CO2 filter for anesthetic circuits that uses patented polymeric hollow fiber membrane technology to separate CO2 from the re-breathing circuit via passive diffusion. The product replaces traditional single-use chemical CO2 absorbents used on Dräger and GE Aisys anesthesia machines, offering a 24-month useful life and is sold directly to hospitals and medical centers.
Is DMF Medical a public or private company?
DMF Medical is a private company. It is classified as founder individual operated bootstrapped and is currently operating.
When was DMF Medical founded?
DMF Medical was founded in 2011. It employs 11 to 50 people.
Where is DMF Medical based?
DMF Medical is headquartered in Halifax, Canada, in the North America region.
How does DMF Medical make money?
One revenue line is on record: medical Device Sales (mem*sorb™).
Who are DMF Medical's main competitors?
Direct peers on record are Teleflex, Penlon, Intersurgical, Armstrong Medical and Vyaire Medical. Broad incumbents are ICU Medical (Smiths Medical), GE HealthCare, Dräger and Philips. Medline Industries is listed as an others.
Does DMF Medical have an API?
No public API is recorded for DMF Medical.
What industry is DMF Medical in?
DMF Medical's product category is Anesthesia CO2 Filtration Medical Devices. Its primary akta.pro industry code is HLAHAGAK, Anesthesia & Respiratory Gas Delivery Equipment (Breathing Circuits, Vaporizers, Gas Mixers). Its NAICS code is 339113.